SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Glofitamab Regimen Improves Survival in DLBCL

2.

Prior authorizations draining time, energy from many cancer patients

3.

The main subject is associated with suicide in the United States.

4.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

5.

Six breast texture patterns linked to higher risk of invasive cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot